Does POLATUZUMAB VEDOTIN Cause Lymphoma? 257 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 257 reports of Lymphoma have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 5.4% of all adverse event reports for POLATUZUMAB VEDOTIN.
257
Reports of Lymphoma with POLATUZUMAB VEDOTIN
5.4%
of all POLATUZUMAB VEDOTIN reports
32
Deaths
11
Hospitalizations
How Dangerous Is Lymphoma From POLATUZUMAB VEDOTIN?
Of the 257 reports, 32 (12.5%) resulted in death, 11 (4.3%) required hospitalization, and 6 (2.3%) were considered life-threatening.
Is Lymphoma Listed in the Official Label?
Yes, Lymphoma is listed as a known adverse reaction in the official FDA drug label for POLATUZUMAB VEDOTIN.
What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?
Disease progression (1,131)
Off label use (692)
Anaemia (344)
Blood lactate dehydrogenase increased (307)
Drug ineffective (305)
Neutropenia (303)
Death (295)
Covid-19 (286)
Febrile neutropenia (286)
Pyrexia (285)
What Other Drugs Cause Lymphoma?
RANITIDINE (1,256)
RITUXIMAB (1,216)
ADALIMUMAB (982)
METHOTREXATE (861)
ETANERCEPT (697)
INFLIXIMAB (671)
CYCLOPHOSPHAMIDE (640)
LENALIDOMIDE (518)
PREDNISONE (490)
VINCRISTINE (422)
Which POLATUZUMAB VEDOTIN Alternatives Have Lower Lymphoma Risk?
POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ
POLATUZUMAB VEDOTIN vs POLIDOCANOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM